LAURIA, ROSSELLA
 Distribuzione geografica
Continente #
EU - Europa 1.851
NA - Nord America 1.673
AS - Asia 1.670
SA - Sud America 237
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 5.483
Nazione #
US - Stati Uniti d'America 1.603
SG - Singapore 899
RU - Federazione Russa 809
IT - Italia 462
CN - Cina 403
BR - Brasile 193
VN - Vietnam 161
DE - Germania 158
HK - Hong Kong 124
NL - Olanda 93
FI - Finlandia 77
UA - Ucraina 68
FR - Francia 59
CA - Canada 43
GB - Regno Unito 41
IN - India 37
IE - Irlanda 26
ZA - Sudafrica 21
AR - Argentina 18
MX - Messico 16
SE - Svezia 15
CI - Costa d'Avorio 13
PL - Polonia 11
EC - Ecuador 10
ES - Italia 10
AT - Austria 7
CO - Colombia 7
IQ - Iraq 7
BD - Bangladesh 6
ID - Indonesia 5
JP - Giappone 5
KR - Corea 5
LT - Lituania 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
HN - Honduras 3
IL - Israele 3
UY - Uruguay 3
UZ - Uzbekistan 3
BZ - Belize 2
CL - Cile 2
DZ - Algeria 2
EU - Europa 2
JM - Giamaica 2
LK - Sri Lanka 2
MA - Marocco 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
VE - Venezuela 2
AM - Armenia 1
AU - Australia 1
BE - Belgio 1
BF - Burkina Faso 1
CV - Capo Verde 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
IR - Iran 1
LY - Libia 1
ME - Montenegro 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
PH - Filippine 1
PK - Pakistan 1
SI - Slovenia 1
TJ - Tagikistan 1
TN - Tunisia 1
TR - Turchia 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
ZW - Zimbabwe 1
Totale 5.483
Città #
Singapore 416
Chandler 242
Moscow 189
Beijing 150
Ashburn 139
Hong Kong 124
Amsterdam 88
Napoli 86
Santa Clara 70
Millbury 59
Los Angeles 55
San Jose 49
Jacksonville 47
Ho Chi Minh City 46
Munich 45
Naples 41
Dallas 40
Princeton 40
Nanjing 34
New York 34
Hanoi 30
Buffalo 25
Dong Ket 24
Turku 23
Helsinki 22
São Paulo 22
Wilmington 20
Des Moines 19
The Dalles 17
Pune 16
Toronto 16
Boston 15
Johannesburg 13
Redondo Beach 13
Seattle 13
Tianjin 13
Hefei 12
Milan 11
Ottawa 11
Montreal 10
Orem 10
Chicago 9
Lawrence 9
Mexico City 9
Shenyang 9
Stockholm 9
Warsaw 9
Brooklyn 8
Falkenstein 8
Falls Church 8
Frankfurt am Main 8
Haiphong 8
London 8
Nanchang 8
Poplar 8
Rome 8
Belo Horizonte 7
Denver 7
Jiaxing 7
Nuremberg 7
Redwood City 7
Rozzano 7
Ann Arbor 6
Casoria 6
Manchester 6
Phoenix 6
Porto Alegre 6
Rio de Janeiro 6
Atlanta 5
Borgomanero 5
Changsha 5
Charlotte 5
Guayaquil 5
Hangzhou 5
Hải Dương 5
Jinan 5
Leawood 5
Ninh Bình 5
Nola 5
Salerno 5
Shanghai 5
Tokyo 5
Augusta 4
Bologna 4
Brasília 4
Chennai 4
Dearborn 4
Dublin 4
Fairfield 4
Menfi 4
Mumbai 4
New Delhi 4
Quito 4
San Francisco 4
San Mateo 4
Taizhou 4
Washington 4
Araraquara 3
Battipaglia 3
Biên Hòa 3
Totale 2.692
Nome #
null 223
Manuale di Oncologia Clinica 193
Long-term disease control with lapatinib and capecitabine in a patient with HER2-positive metastatic breast cancer pretreated with trastuzumab and trastuzumab-emtansine 155
Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy 153
Epigenetic silencing of THY1 tracks the acquisition of the Notch1-EGFR signaling in a xenograft model of CD44+/CD24low/CD90+ myoepithelial cells 145
A randomised factorial trial of sequential doxorubicin and CMF vs CMF and chemotherapy alone vs chemotherapy followed by goserelin plus tamoxifen as adjuvant treatment of node-positive breast cancer. 139
Combined effect of obesity and diabetes on early breast cancer outcome: A prospective observational study 124
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. 123
Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era 122
Systemic treatment of malignant gastrointestinal neuroectodermal tumour after childhood neuroblastoma: chemotherapy in malignant gastrointestinal neuroectodermal tumour 121
Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study 121
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. 119
Palbociclib added to ongoing endocrine therapy for hormone receptor-positive HER2-negative metastatic breast cancer: A case report series 119
Long-term survival and BRCA status in male breast cancer: A retrospective single-center analysis 116
Tumor characteristics and prognosis in familial breast cancer 116
Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI) 115
Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study 113
It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature 113
Core curriculum. Oncologia clinica 110
Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues 108
Decision making in borderline ovarian tumors: report of a rare case of mesosigma psammocarcinoma 107
Tumor segmentation analysis at different post-contrast time points: A possible source of variability of quantitative DCE-MRI parameters in locally advanced breast cancer 107
Chlorambucil, Vincristine and Cytarabine (COA) treatment of low grade lymphomas 106
Fractional microablative CO2 laser in breast cancer survivors affected by iatrogenic vulvovaginal atrophy after failure of nonestrogenic local treatments: a retrospective study 105
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study). 104
Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab. 104
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study. 103
Taxane-Based Combinations As Adjuvant Chemotherapy of Early Breast Cancer: A Meta-Analysis of Randomized Trials 103
Partial deficiency of adrenal 11-hydroxylase: A possible cause of primary hypertension 103
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study. 99
Changing presentation in non Hodgkin lymphoma". 98
Advanced and Locally unresectable gastric carcinoma: five years of survival with good quality of life. 98
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 98
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancer. 97
Capitolo 15: i Tumori Ginecologici 97
Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054] 96
Tailored therapy for aggressive non-Hodgkin’s lymphoma: results of a phase II study with a long-term follow-up. 96
CAVBP-DEP Altemative Chemotherapy for the treatment of intermediate and high grade non Hodgkin lymphoma: final results of a pilot study. 96
Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease. 95
Core curriculum. Oncologia clinica 93
Salvage chemotherapy with CCNU and methotrexate for small cell lung cancer resistant to CAV/PE alternating chemotherapy. 91
Bone involvement by adenocarcinoma of the uterine cervix: a rare entity 89
Comparison of Tropisetron (ICS 205-930) with alizapride plus dexamethasone in the prevention of emesis induced by repeated cisplatin administration. 88
: Low dose dopamine induces early recovery of recombinant Interleukin-2 impaired renal function. 87
Maintenance therapy with recombinant Interferon Alpha-2b (IFN) in prognostically in prognastically unfavourable aggressive non-Hodgkin’s lymphomas. 85
Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) randomized study. 82
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: safety data from the multicentre phase 3 randomised ELDA trial. 77
'Primary Bone Lymphoma". 76
Salvage chemotherapy for non Hodgldn's lymphoma of unfavorable histology with a combination of CCNU and Vinblastine. 69
null 67
First-line systemic therapy for metastatic breast cancer and management of pleural effusion. 63
Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safety 47
Totale 5.574
Categoria #
all - tutte 17.992
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.992


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 0 0 0 0 26 8 34 3 32 29
2021/2022342 8 1 7 5 3 13 6 9 26 40 111 113
2022/2023523 57 65 18 42 57 54 3 39 74 92 16 6
2023/2024284 11 52 32 22 17 47 5 29 4 5 48 12
2024/20251.563 63 42 13 20 66 80 137 117 89 152 669 115
2025/20261.915 317 171 341 317 544 165 60 0 0 0 0 0
Totale 5.574